The efficacy of dupilumab on patients who have atopic dermatitis (AD) with overlying allergic contact dermatitis (ACD) is not known.
To address this, a study was conducted, testing the response rate of dupilumab in AD patients with ACD.
While this study was limited by a small sample size, results did not show a difference between AD patients with and without ACD when using dupilumab.
Read more on this study at the Journal of the American Academy of Dermatology.